Health Care
Washington, D.C. – Energy and Commerce Committee Chairman Frank Pallone, Jr. (D-NJ) released the following statement today on the bicameral agreement to lower prescription drug prices for Americans in the Build Back Better Act:
Washington, DC – Congressman Frank Pallone, Jr. (NJ-06)'s bipartisan bill to improve drug quality, reduce drug shortages, and make pharmaceutical production more efficient passed the U.S. House of Representatives today.
Washington, DC – Congressman Frank Pallone, Jr. (NJ-06) today announced that federally qualified health centers in New Jersey will receive $17,761,572 from the American Rescue Plan. The funding will support construction, expansion, renovation, and other capital improvements to improve health care infrastructure.
Washington, D.C. – Energy and Commerce Committee Chairman Frank Pallone, Jr. (D-NJ) released the following statement today after the Energy and Commerce Committee passed its provisions of the Build Back Better Act:
Washington, DC – Congressman Frank Pallone, Jr. (NJ-06) today announced that he is including $2.86 billion for the 9/11 World Trade Center (WTC) Health Program in the Energy and Commerce Committee's portion of the Build Back Better Act, which will be marked up next week.
New Brunswick, NJ – Congressman Frank Pallone, Jr. (NJ-06) and U.S. Department of Health and Human Services (HHS) Secretary Xavier Becerra joined Protect Our Care's bus tour rally today to highlight the urgent need to pass transformative legislation to lower prescription drug prices.
Washington, DC – Congressman Frank Pallone, Jr. (NJ-06) today announced that seven requests for Community Funded Projects he submitted to the Appropriations Committee for New Jersey's Sixth Congressional District passed in the House of Representatives. The remaining requests Pallone made are expected to receive a vote in the coming months.
The projects that passed the House include:
Washington, DC – Congressman Frank Pallone, Jr. (NJ-06) announced that his bipartisan bill to improve drug quality, reduce drug shortages, and make pharmaceutical production more efficient advanced in the U.S. House of Representatives today.